Shares of HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fifteen research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating, eleven have given a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $110.3571.
Several research firms have commented on HQY. Jefferies Financial Group set a $108.00 price target on HealthEquity in a report on Thursday, February 19th. Barclays lowered their price objective on HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 18th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research report on Thursday, January 22nd. JPMorgan Chase & Co. lowered their price target on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a report on Wednesday, March 18th. Finally, Citizens Jmp set a $122.00 price objective on shares of HealthEquity in a report on Thursday, December 4th.
Read Our Latest Report on HealthEquity
HealthEquity Stock Performance
HealthEquity (NASDAQ:HQY – Get Free Report) last announced its quarterly earnings data on Tuesday, March 17th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.05. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The business had revenue of $334.59 million during the quarter, compared to analyst estimates of $332.48 million. The business’s quarterly revenue was up 7.3% compared to the same quarter last year. Equities research analysts forecast that HealthEquity will post 2.32 EPS for the current year.
Institutional Investors Weigh In On HealthEquity
Institutional investors have recently added to or reduced their stakes in the stock. Acumen Wealth Advisors LLC acquired a new position in shares of HealthEquity in the 4th quarter worth approximately $27,000. Aster Capital Management DIFC Ltd bought a new stake in HealthEquity in the fourth quarter valued at $28,000. Caitong International Asset Management Co. Ltd raised its stake in HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after acquiring an additional 293 shares in the last quarter. True Wealth Design LLC lifted its holdings in shares of HealthEquity by 3,522.2% during the third quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after acquiring an additional 317 shares during the period. Finally, Farther Finance Advisors LLC boosted its stake in shares of HealthEquity by 59.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock valued at $37,000 after purchasing an additional 146 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.
HealthEquity Company Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
See Also
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
